← back to search

Peirong Ding

Wuhan Union Hospital · CN
Area of research
Oncology · Surgery
Research interest
Research interests include Colorectal Cancer Surgical Treatments, Colorectal Cancer Treatments and Studies, Colorectal and Anal Carcinomas, and Genetic factors in colorectal cancer.
h-index
28
citations
3,217
works
188
NIH funding
primary concept
Medicine
email

Recent publications

Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors
Cancer Cell 2025cited by 25position: middledoi
Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer
Cancer Letters 2025cited by 17position: middledoi
Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study
Cancer Cell 2025cited by 12position: middledoi
Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer
Nature Communications 2024cited by 43position: lastdoi
Risks of Organ Preservation in Rectal Cancer: Data From Two International Registries on Rectal Cancer
Journal of Clinical Oncology 2024cited by 28position: middledoi
Long-Term Outcomes of dMMR/MSI-H Rectal Cancer Treated With Anti–PD-1–Based Immunotherapy as Curative-Intent Treatment
Journal of the National Comprehensive Cancer Network 2024cited by 23position: lastdoi
A growth factor-reduced culture system for colorectal cancer organoids
Cancer Letters 2024cited by 18position: middledoi
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial
PLoS Medicine 2024cited by 17position: middledoi
Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair–Deficient Colorectal Cancer
Journal of the National Comprehensive Cancer Network 2023cited by 40position: lastdoi
Locally advanced rectal cancer with dMMR/MSI-H may be excused from surgery after neoadjuvant anti-PD-1 monotherapy: a multiple-center, cohort study
Frontiers in Immunology 2023cited by 26position: middledoi
A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study
Diseases of the Colon & Rectum 2023cited by 16position: middledoi
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
Cell Research 2022cited by 172position: middledoi
Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer
Nature Communications 2022cited by 147position: lastdoi
Comprehensive profiling of 1015 patients’ exomes reveals genomic-clinical associations in colorectal cancer
Nature Communications 2022cited by 82position: middledoi
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial
Annals of Surgery 2022cited by 80position: lastdoi
Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review
Frontiers in Immunology 2022cited by 65position: lastdoi
Clinical actionability of triaging DNA mismatch repair deficient colorectal cancer from biopsy samples using deep learning
EBioMedicine 2022cited by 42position: lastdoi
Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study
European Journal of Cancer 2022cited by 39position: lastdoi
Anatomic patterns and clinical significance of gastrocolic trunk of Henlé in laparoscopic right colectomy for colon cancer: Results of the HeLaRC trial
International Journal of Surgery 2022cited by 20position: middledoi
Predicting treatment response from longitudinal images using multi-task deep learning
Nature Communications 2021cited by 213position: middledoi
Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
Journal of Hematology & Oncology 2021cited by 182position: middledoi
The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy
Radiation Oncology 2021cited by 108position: middledoi
Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer
Journal for ImmunoTherapy of Cancer 2021cited by 59position: lastdoi
Serum piRNA-54265 is a New Biomarker for early detection and clinical surveillance of Human Colorectal Cancer
Theranostics 2020cited by 94position: middledoi
Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment
International Journal of Pharmaceutics 2019cited by 59position: middledoi
Anatomical characteristics and classifications of gastrocolic trunk of Henle in laparoscopic right colectomy: preliminary results of multicenter observational study
Surgical Endoscopy 2019cited by 21position: middledoi
PIWI-interacting RNA-54265 is oncogenic and a potential therapeutic target in colorectal adenocarcinoma
Theranostics 2018cited by 165position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhizhong Pan · Sun Yat-sen University8 papers (2021–2025)Jinghua Tang · Sun Yat-sen University7 papers (2021–2024)Wei-Jian Mei · Sun Yat-sen University7 papers (2022–2025)Jiang Wu · Xihua University6 papers (2021–2024)Binyi Xiao · Sun Yat-sen University5 papers (2021–2024)Ling-Heng Kong · Sun Yat-sen University5 papers (2021–2024)Kai Han · China Agricultural University5 papers (2021–2024)Jiehai Yu · Sun Yat-sen University4 papers (2022–2024)Leen Liao · Sun Yat-sen University4 papers (2021–2025)Dandan Li · China University of Geosciences (Beijing)4 papers (2022–2024)Xiaoshi Zhang · Sun Yat-sen University4 papers (2022–2024)Jian Zheng · University of Louisville3 papers (2020–2022)Li Li · BGI Group (China)3 papers (2021–2022)Qiaoqi Sui · Sun Yat-sen University3 papers (2020–2022)Yihong Ling · Sun Yat-sen University2 papers (2021–2022)Feng Gao · Sun Yat-sen University2 papers (2021–2023)Qi Zhao · Academy of Medical Sciences2 papers (2021–2025)Yong Cheng · The First Affiliated Hospital, Sun Yat-sen University2 papers (2022–2024)Feng Wang · Sun Yat-sen University2 papers (2021–2025)Yuan Li · Shandong University of Traditional Chinese Medicine2 papers (2021–2022)